DNA Drug Development Drug Trials Therapies 
Drug Discovery World
JANUARY 17, 2024
This, coupled with a growing understanding of the heterogeneity of cancer as the basis for treatment resistance, tumour evolution and therefore the main source of therapeutic failure, 6 has highlighted the importance of developing personalised therapy.
Drug Discovery World
OCTOBER 6, 2022
Jarret Glasscock , PhD, CEO of Cofactor Genomics explains how diagnostics are emerging as the key to ensuring the right patients get matched to the right therapy, at the right time. . In pursuit of this, the number of new therapeutics in development has boomed.
Expert insights. Personalized for you.
147 
Let's personalize your content